- CH₣2.71bn
- CH₣2.90bn
- €590.58m
Annual cashflow statement for Medacta SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 37.1 | 51.5 | 46.2 | 47.4 | 72.9 |
| Depreciation | |||||
| Non-Cash Items | 12.4 | 15.7 | 25.6 | 30 | 30.8 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -26.9 | -53.6 | -49.8 | -60.7 | -62.3 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 59.6 | 54.1 | 73.5 | 75.1 | 107 |
| Capital Expenditures | -37.4 | -54.6 | -71.3 | -82.2 | -105 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 3.19 | 2.58 | 6.16 | 1.61 | 5.82 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Change in Net Investments | |||||
| Cash from Investing Activities | -34.2 | -52 | -65.1 | -80.6 | -98.9 |
| Financing Cash Flow Items | — | — | -10.4 | — | — |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -6.03 | -31.2 | 3.44 | -10.1 | 4.33 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 20.8 | -27.7 | 11.9 | -11.5 | 10.8 |